Compounds > 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Syndrome

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Syndrome in 1 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Syndrome: A characteristic symptom complex.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosenberger, G1
Meien, S1
Kutsche, K1

Other Studies

1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Syndrome

ArticleYear
Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome.
    Human mutation, 2009, Volume: 30, Issue:3

    Topics: Abnormalities, Multiple; Cells, Cultured; Chromones; Craniofacial Abnormalities; Enzyme Inhibitors;

2009